Advanced Plant Pharmaceuticals/World Health Energy to Utilize New Higher Yielding Biodiesel Production Process of Ultrasonication

Ultrasonication Process Significantly More Efficient Than Industry Standard Batch Reactors Process


NEW YORK, Jan. 12, 2007 (PRIME NEWSWIRE) -- Advanced Plant Pharmaceuticals, Inc. (OTCBB:APPI) and World Health Energy, Inc. announced that the company will be utilizing a more efficient biodiesel process known as ultrasonication. The higher yielding process will provide the company with production cost advantages.

Currently, biodiesel is produced primarily in batch reactors where required energy is provided by heating and mechanical mixing. However, ultrasonic processing is a more effective process to attain the required mixing while providing the necessary activation energy. Through the use of ultrasonication, a biodiesel yield in excess of 99% can be achieved in a remarkably short time duration of less than 5 minutes in comparison to one hour or more using conventional batch reactor systems. World Health Energy will utilize ultrasonication to benefit from the enhanced efficiency and superior end product quality compared to the standard batch reactors process.

Ultrasonic extraction can greatly accelerate extraction processes. Using an ultrasonic reactor, ultrasonic waves are used to create cavitation bubbles in a solvent material. When these bubbles collapse near the cell walls, it creates shock waves and liquid jets that cause those cells' walls to break and release their contents into the solvent. The solvent is processed into biodiesel.

the company is working towards the most immediate goal of closing on the $1.2 million financing previously announced for the construction of two bio-diesel plants slated for Kentucky and Florida. Upon closing on the financing, the company will provide details on the construction of the first biodiesel plant.

An 8-K for the merger with World Health Energy will be filed after the satisfaction of the closing conditions which include, without limitation, issuance and receipt of all consideration relating to the transaction and other customary closing conditions.

To be added to APPI's corporate e-mail list for shareholders and interested investors, please send an e-mail to ir@advancedplantpharm.com.

About World Health Energy

World Health Energy, Inc. plans to use renewable, cost-effective agricultural products from around the world to develop natural alternative fuels. WHE's proposed biodiesel production plants are designed to produce biodiesel that complies to or exceeds international biodiesel production requirements and standards, including the European standard for Biodiesel EN 14214, as well as ASTM D6751 specifications.

"Safe Harbor Statement" Under The Private Securities Litigation Reform Act Of 1995

This press release contains forward-looking statements that involve risks and uncertainties. The statements in this release are forward-looking statements that are made pursuant to safe harbor provision of the Private Securities Litigation Reform Act of 1995. Actual results, events and performance could vary materially from those contemplated by these forward-looking statements. These statements involve known and unknown risks and uncertainties, which may cause Advanced Plant Pharmaceuticals, Inc.'s actual results in future periods to differ materially from results expressed or implied by forward-looking statements. These risks and uncertainties include, among other things, product demand and market competition. You should independently investigate and fully understand all risks before making investment decisions.


            

Kontaktdaten